Long term treatment with insulin-stimulating agent, nateglinide, ameliorates insulin resistance in type 2 diabetic patients

被引：0
|
作者：
Inukai, Kouichi
Nakashima, Youhei
Ikegami, Yuichi
Imai, Kenta
Awata, Takuya
Katayama, Shigehiro
机构：
来源：
DIABETES | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A483 / A483
页数：1
相关论文
共 50 条
  • [31] Study of nateglinide in Japan: Long-term treatment of patients with type 2 diabetes
    Hiroto Taki
    Toshio Maki
    Takako Iso
    Kenji Iwamoto
    Taiichi Kajiura
    Advances in Therapy, 2006, 23 : 307 - 324
  • [32] Study of nateglinide in Japan: Long-term treatment of patients with type 2 diabetes
    Taki, H
    Maki, T
    Iso, T
    Iwamoto, K
    Kajiura, T
    ADVANCES IN THERAPY, 2006, 23 (02) : 307 - 324
  • [33] Long-Term Continuous, Subcutaneous Insulin Infusion Treatment Improved Insulinogenic Index and Proinsulin-to-Insulin Ratio in Longstanding Type 2 Diabetic Patients
    Noh, Yun-Hee
    Lee, Jun-Ho
    Lee, Ju-Han
    Park, Jin-Hee
    Kim, Seonguk
    Choi, Soo-Bong
    DIABETES, 2009, 58 : A61 - A61
  • [34] Adherence to insulin treatment in insulin naive type 2 diabetic patients: results of telephonic intervention
    Yavuz, D. Gogas
    Bilen, H.
    Sancak, S.
    Galip, T.
    Hekimsoy, Z.
    Sahin, I.
    Yilmaz, M.
    Aydin, H.
    Atmaca, A.
    Sert, M.
    Karakaya, P.
    Arpaci, D.
    Oguz, A.
    Guvener, N.
    DIABETOLOGIA, 2014, 57 : S385 - S385
  • [35] Insulin Sensitizing Agent, Pioglitazone, Decreases Blood Pressure along with Reduction of Insulin Resistance in Type 2 Diabetic Patients with Metabolic Syndrome.
    Hashimoto, S.
    Yatabe, J.
    Sanada, H.
    Watanabe, T.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [36] Effect of a short-term intravenous insulin-infusion on severe insulin-resistance in insulin-dependent type 2-diabetic patients
    Biesenbach, G
    Grafinger, P
    DIABETES, 2001, 50 : A430 - A431
  • [37] Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment
    Ilkova, H
    Glaser, B
    Tunckale, A
    Bagriacik, N
    Cerasi, E
    DIABETES CARE, 1997, 20 (09) : 1353 - 1356
  • [38] INSULIN RESISTANCE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS WITH HYPERTRIGLYCERIDEMIA
    WIDEN, E
    EKSTRAND, A
    SALORANTA, C
    FRANSSILAKALLUNKI, A
    ERIKSSON, J
    SCHALINJANTTI, C
    GROOP, L
    DIABETOLOGIA, 1992, 35 (12) : 1140 - 1145
  • [39] The impaired acute insulin response in newly diagnosed Type 2 diabetic patients can be restored by nateglinide and repaglinide
    Wang, FN
    Liao, ZH
    Yao, B
    Li, YB
    Hu, GL
    Weng, JP
    DIABETOLOGIA, 2004, 47 : A254 - A254
  • [40] Formononetin Treatment in Type 2 Diabetic Rats Reduces Insulin Resistance and Hyperglycemia
    Oza, Manisha J.
    Kulkarni, Yogesh A.
    FRONTIERS IN PHARMACOLOGY, 2018, 9
12345